Devonian Health Group (TSXV:GSD) FCF Margin % : -21.07% (As of Jan. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Devonian Health Group's Free Cash Flow for the three months ended in Jan. 2025 was C$-1.86 Mil. Devonian Health Group's Revenue for the three months ended in Jan. 2025 was C$8.83 Mil. Therefore, Devonian Health Group's FCF Margin % for the quarter that ended in Jan. 2025 was -21.07%.

As of today, Devonian Health Group's current FCF Yield % is 27.47%.

The historical rank and industry rank for Devonian Health Group's FCF Margin % or its related term are showing as below:

TSXV:GSD' s FCF Margin % Range Over the Past 10 Years
Min: -185.76 Med: -95.99 Max: 31.6
Current: 25.32

During the past 11 years, the highest FCF Margin % of Devonian Health Group was 31.60%. The lowest was -185.76%. And the median was -95.99%.

TSXV:GSD's FCF Margin % is ranked better than
92.29% of 999 companies
in the Biotechnology industry
Industry Median: -120.51 vs TSXV:GSD: 25.32

Devonian Health Group FCF Margin % Historical Data

The historical data trend for Devonian Health Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group FCF Margin % Chart

Devonian Health Group Annual Data

Trend

Jun15

Jun16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

FCF Margin %

Get a 7-Day Free Trial

-95.99

-125.22

-128.03

-185.76

31.60

Devonian Health Group Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
FCF Margin %	Get a 7-Day Free Trial															-14.65	5.03	69.23	44.51	-21.07

Competitive Comparison of Devonian Health Group's FCF Margin %

For the Biotechnology subindustry, Devonian Health Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devonian Health Group's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Devonian Health Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Devonian Health Group's FCF Margin for the fiscal year that ended in Jul. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jul. 2024 )	/	Revenue (A: Jul. 2024 )
	=	5.63	/	17.816
	=	31.60 %

Devonian Health Group's FCF Margin for the quarter that ended in Jan. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2025 )	/	Revenue (Q: Jan. 2025 )
	=	-1.86	/	8.828
	=	-21.07 %

Devonian Health Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

DVHGF:USA

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines